# Evident Vascular

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/evident-vascular

- Industry: Medical Devices & Equipment
- Headquarters: San Jose, US
- Website: www.evidentvascular.com
- Total disclosed funding: $20M
- Latest round: Series B (Mar 25, 2025)
- Investors on record: 2

## About

Based in California, US, and founded in 2021 by Howard Rosen (CEO), Patrick Phillips, and Danielo Piazza, Evident Vascular, Inc. operates as a Medical device distributor of Intravascular ultrasound. In March 2025, Evident Vascular, Inc. raised an undisclosed amount of series B funding from new investors Shangbay Capital and Vensana Capital, with participation from other unspecified investors. Evident Vascular is a business that is creating an artificial intelligence (AI)-powered intravascular ultrasound (IVUS) platform to meet the needs of peripheral vascular image-guided therapy. The company is intended to deliver higher image quality, interpretation help, ease of use, and peripheral vascular navigation. The company thinks that its IVUS platform can assist ensure that patients with peripheral vascular disease (PVD) receive the best possible treatment. The company will use the March 2025 funding to accelerate the development of its advanced IVUS technology designed to enhance vascular imaging and patient outcomes and support 510(k) FDA clearance ahead of U.S. market launch.

## Funding rounds

- Series B, Mar 25, 2025 — ShangBay Capital, Vensana Capital
- Series A, Oct 17, 2023, $20M — Vensana Capital

## Investors

- Vensana Capital (https://capitalatlas.ai/funds/vensana-capital) — Series A, Series B
- ShangBay Capital (https://capitalatlas.ai/funds/shangbay-capital) — Series B